|
Sweden says AstraZeneca used questionable asthma drug API from Indian plant
FiercePharma Manufacturing AstraZeneca ($AZN) said last week it was closing a plant in India that made the API for asthma drugs, noting there is not much demand any longer for the terbutaline sulfate it makes. But what the U.K. company did not say was that before its closing … |
View full post on asthma – Google News